Clinical evaluation of two daily doses of naproxen and indomethacin: result of a double-blind crossover trial

Reference

• Beck E. R. Naproxen (Naprosyn) and gastro-intestinal haemorrhage. Brit. med. J. 1974; 1: 5721. Beck E. R. Naproxen (Naprosyn) and gastro-intestinal haemorrhage. Brit. med. J. 1974; 1: 572
   PubMedGoogle Scholar
• Brogden R. N., Pinder R. M., Sawyer P. R., Speight T. M., Avery G. S. Naproxen: a review of its pharmacological properties and therapeutic efficacy and use. Drugs 1975; 9: 3262. Brogden R. N., Pinder R. M., Sawyer P. R., Speight T. M., Avery G. S. Naproxen: a review of its pharmacological properties and therapeutic efficacy and use. Drugs 1975; 9: 326
   PubMed Web of Science ®Google Scholar
• Chaplin M. D., Roszkowski A. P., Richards R. K. Displacement of thiopental (TP) from plasmaproteins by naproxen (D-2 (6′methoxy-2′-naphthyl)-propionic acid). Pharmacologist 1970; 12: 2443. Chaplin M. D., Roszkowski A. P., Richards R. K. Displacement of thiopental (TP) from plasmaproteins by naproxen (D-2 (6′methoxy-2′-naphthyl)-propionic acid). Pharmacologist 1970; 12: 244
   Google Scholar
• Cuthbert M. F. Adverse reactions to non-steroidal antirheumatic drugs. Curr. med. Res. Opin. 1974; 2: 6004. Cuthbert M. F. Adverse reactions to non-steroidal antirheumatic drugs. Curr. med. Res. Opin. 1974; 2: 600
   PubMed Web of Science ®Google Scholar
• Deodhar S. D., Dick W. C., Hodgkinson R., Buchanan W. W. Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis. Quart. J. Med. 1973; 42: 3875. Deodhar S. D., Dick W. C., Hodgkinson R., Buchanan W. W. Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis. Quart. J. Med. 1973; 42: 387
   PubMedGoogle Scholar
• Diamond H., Alexander S., Kuzell W., Lussier A., Odone D., Tompkins R. A multi-center double-blind crossover comparison study of naproxen and aspirin in patients with rheumatoid arthritis. Scand.J. Rheumatol., Suppl. 1973; 2: 1716. Diamond H., Alexander S., Kuzell W., Lussier A., Odone D., Tompkins R. A multi-center double-blind crossover comparison study of naproxen and aspirin in patients with rheumatoid arthritis. Scand.J. Rheumatol., Suppl. 1973; 2: 171
   PubMedGoogle Scholar
• Dick W. C., Collins K. E., Buchanan W. W. Clinical studies on inflammation in small diarthrodial joints. Technetium (*mTc) percentage uptakes in various arthritides and studies on the effect of aspirin in rheumatoid arthritis. Clin. Sci. 1972; 42: 3837. Dick W. C., Collins K. E., Buchanan W. W. Clinical studies on inflammation in small diarthrodial joints. Technetium (*mTc) percentage uptakes in various arthritides and studies on the effect of aspirin in rheumatoid arthritis. Clin. Sci. 1972; 42: 383
   PubMed Web of Science ®Google Scholar
• Dick W. C., Deodhar S. D., Provan C. J., Nuki G., Buchanan W. W. Isotope studies in normal and diseased knee joints: 98mTc uptake related to clinical assessment and to synovial perfusion measured by the (133Xe) clearance technique. Clin. Sci. 1971; 40: 3278. Dick W. C., Deodhar S. D., Provan C. J., Nuki G., Buchanan W. W. Isotope studies in normal and diseased knee joints: 98mTc uptake related to clinical assessment and to synovial perfusion measured by the (133Xe) clearance technique. Clin. Sci. 1971; 40: 327
   PubMed Web of Science ®Google Scholar
• Dick W. C., Grayson M. F., Woodburn A., Nuki G., Buchanan W. W. Indices of inflammatory activity. Relationship between isotope studies and clinical methods. Ann. rheum. Dis. 1970; 29: 6439. Dick W. C., Grayson M. F., Woodburn A., Nuki G., Buchanan W. W. Indices of inflammatory activity. Relationship between isotope studies and clinical methods. Ann. rheum. Dis. 1970; 29: 643
   PubMed Web of Science ®Google Scholar
• Dick W. C., Neufeld R. R., Prentice A. G., Woodburn A., Whaley K., Nuki G., Buchanan W. W. Measurement of joint inflammation: a radioisotope method. Ann. rheum. Dis. 1970; 29: 13510. Dick W. C., Neufeld R. R., Prentice A. G., Woodburn A., Whaley K., Nuki G., Buchanan W. W. Measurement of joint inflammation: a radioisotope method. Ann. rheum. Dis. 1970; 29: 135
   PubMed Web of Science ®Google Scholar
• D'Omezon Y. Etude des cliniciens francais sur Taction de naproxene dans la P.C.E. Scand. J. Rheumatol. 1973; 2: 164, Suppl.11. D'Omezon Y. Etude des cliniciens francais sur Taction de naproxene dans la P.C.E. Scand. J. Rheumatol. 1973; 2: 164, Suppl.
   Google Scholar
• Ellis D. J., Martin B. The plasma protein binding properties of a new nonsteroidal anti-inflammatory agent. Fed. Proc 1971; 30: 120012. Ellis D. J., Martin B. The plasma protein binding properties of a new nonsteroidal anti-inflammatory agent. Fed. Proc 1971; 30: 1200
   Google Scholar
• Fried J. H., Harrison I. T., Lewis B., Riegl J., Rooks W., Tomolonis A. Structure activity relationship among 6-substituted-2-naphthylacetic acids. Scand. J. Rheumatol. 1973; 2: 7, Suppl.13. Fried J. H., Harrison I. T., Lewis B., Riegl J., Rooks W., Tomolonis A. Structure activity relationship among 6-substituted-2-naphthylacetic acids. Scand. J. Rheumatol. 1973; 2: 7, Suppl.
   Google Scholar
• Hallesy D. W., Shott L. D., Hill R. Comparative toxicology of naproxen. Scand. J. Rheumatol. 1973; 2: 20, Suppl.14. Hallesy D. W., Shott L. D., Hill R. Comparative toxicology of naproxen. Scand. J. Rheumatol. 1973; 2: 20, Suppl.
   PubMedGoogle Scholar
• Halvorsen L., Dotevall G., Sevelius H. Comparative effects of aspirin and naproxen on gastric mucosa. Scand. J. Rheumatol. 1973; 2: 43, Suppl.15. Halvorsen L., Dotevall G., Sevelius H. Comparative effects of aspirin and naproxen on gastric mucosa. Scand. J. Rheumatol. 1973; 2: 43, Suppl.
   PubMedGoogle Scholar
• Harrison I. T., Lewis B., Nelson P., Rooks W., Roszkowski A., Tomolonis A., Fried J. H. Non-steroidal anti-inflammatory agents. I. 6-substituted 2-naphthylacetic acids. J. med. Chem. 1970; 13: 20316. Harrison I. T., Lewis B., Nelson P., Rooks W., Roszkowski A., Tomolonis A., Fried J. H. Non-steroidal anti-inflammatory agents. I. 6-substituted 2-naphthylacetic acids. J. med. Chem. 1970; 13: 203
   PubMed Web of Science ®Google Scholar
• Hart F. D. Naproxen (Naprosyn) and gastro-intestinal haemorrhage. Brit. med. J. 1974; 2: 5117. Hart F. D. Naproxen (Naprosyn) and gastro-intestinal haemorrhage. Brit. med. J. 1974; 2: 51
   PubMed Web of Science ®Google Scholar
• Helby-Petersen P., Ibfelt H., Rossel I. A double-blind crossover comparison of naproxen and placebo in rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 145, Suppl.18. Helby-Petersen P., Ibfelt H., Rossel I. A double-blind crossover comparison of naproxen and placebo in rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 145, Suppl.
   PubMedGoogle Scholar
• Hill H. F. H., Hill A. G. S., Mowat A. G., Ansell B. M., Mathews J. A., Seifert M. H., Gumpel J. M., Christie G. A. Multi-centre double-blind crossover trial comparing naproxen and aspirin in rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 176, Suppl.19. Hill H. F. H., Hill A. G. S., Mowat A. G., Ansell B. M., Mathews J. A., Seifert M. H., Gumpel J. M., Christie G. A. Multi-centre double-blind crossover trial comparing naproxen and aspirin in rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 176, Suppl.
   Google Scholar
• Hill H. F. H., Hill A. G. S., Mowat A. G., Ansell B. M., Mathews J. A., Seifert M. H., Gumpel J. M., Christie G. A. Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis. Ann. rheum. Dis. 1974; 33: 1220. Hill H. F. H., Hill A. G. S., Mowat A. G., Ansell B. M., Mathews J. A., Seifert M. H., Gumpel J. M., Christie G. A. Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis. Ann. rheum. Dis. 1974; 33: 12
   PubMed Web of Science ®Google Scholar
• Jasani M. K., Downie W. W., Samuels B. M., Buchanan W. W. Ibuprofen in rheumatoid arthritis. Clinical study of analgesic and anti-inflammatory activity. Ann. rheum. Dis. 1968; 27: 45721. Jasani M. K., Downie W. W., Samuels B. M., Buchanan W. W. Ibuprofen in rheumatoid arthritis. Clinical study of analgesic and anti-inflammatory activity. Ann. rheum. Dis. 1968; 27: 457
   PubMed Web of Science ®Google Scholar
• Katona G. Four years of clinical experience with naproxen and objective methods of evaluation. Scand. J. Rheumatol. 1973; 2: 101, Suppl.22. Katona G. Four years of clinical experience with naproxen and objective methods of evaluation. Scand. J. Rheumatol. 1973; 2: 101, Suppl.
   PubMedGoogle Scholar
• Kogstad D. A double-blind crossover study of naproxen and indomethacin in patients with rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 159, Suppl.23. Kogstad D. A double-blind crossover study of naproxen and indomethacin in patients with rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 159, Suppl.
   Google Scholar
• Lee P., Baxter A., Dick W. C., Webb J. An assessment of grip strength measurements in rheumatoid arthritis. Scand. J. Rheumatol. 1974; 3: 1724. Lee P., Baxter A., Dick W. C., Webb J. An assessment of grip strength measurements in rheumatoid arthritis. Scand. J. Rheumatol. 1974; 3: 17
   PubMed Web of Science ®Google Scholar
• Lussier A., Myhal D., Boost G., Varady J., Segre E., Strauss W. Long-term study of naproxen challenged by a short-term double-blind crossover study with placebo in rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 113, Suppl.25. Lussier A., Myhal D., Boost G., Varady J., Segre E., Strauss W. Long-term study of naproxen challenged by a short-term double-blind crossover study with placebo in rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 113, Suppl.
   PubMedGoogle Scholar
• Reynolds P. M. G., Whorwell P. J. A single-blind crossover comparison of fenoprofen, ibuprofen and naproxen in rheumatoid arthritis. Curr. med. Res. Opin. 1974; 2: 46126. Reynolds P. M. G., Whorwell P. J. A single-blind crossover comparison of fenoprofen, ibuprofen and naproxen in rheumatoid arthritis. Curr. med. Res. Opin. 1974; 2: 461
   PubMed Web of Science ®Google Scholar
• Ritchie D. M., Boyle J. A., Mclnnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Quart. J. Med. (N.S.) 1968; 37: 39327. Ritchie D. M., Boyle J. A., Mclnnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Quart. J. Med. (N.S.) 1968; 37: 393
   PubMedGoogle Scholar
• Rooks W. H. The activity of D-2-(6′-methoxy-2′-naphthyl) propionic acid (naproxen) versus adjuvant-induced arthritis. Fed. Proc 1971; 30, Abstr. 38628. Rooks W. H. The activity of D-2-(6′-methoxy-2′-naphthyl) propionic acid (naproxen) versus adjuvant-induced arthritis. Fed. Proc 1971; 30, Abstr. 386
   Google Scholar
• Ropes M. W., Bennett G. A., Cobb S., Jacox R., Jessar R. A. Diagnostic criteria for rheumatoid arthritis. 1958 Revision. Bull, rheum. Dis. 1959; 9: 17529. Ropes M. W., Bennett G. A., Cobb S., Jacox R., Jessar R. A. Diagnostic criteria for rheumatoid arthritis. 1958 Revision. Bull, rheum. Dis. 1959; 9: 175
   Google Scholar
• Roszkowski A. P., Rooks W., Tomolonis A., Miller L. M., Pelezarska A. B. Pharmacological properties of naproxen. Scand. J. Rheumatol. 1973; 2: 12, Suppl.30. Roszkowski A. P., Rooks W., Tomolonis A., Miller L. M., Pelezarska A. B. Pharmacological properties of naproxen. Scand. J. Rheumatol. 1973; 2: 12, Suppl.
   Google Scholar
• Roth S. H. Safety and efficacy of Naprosyn therapy in rheumatoid arthritis patients with upper gastro-intestinal dysfunction. Naprosyn in the treatment of Rheumatic Diseases. Proceedings of a Symposium held in London, October 1973, 1973; 50, Syntex31. Roth S. H. Safety and efficacy of Naprosyn therapy in rheumatoid arthritis patients with upper gastro-intestinal dysfunction. Naprosyn in the treatment of Rheumatic Diseases. Proceedings of a Symposium held in London, October 1973, 1973; 50, Syntex
   Google Scholar
• Runkel R., Chaplin M., Boost G., Segre E., Forchielli E. Absorption, distribution, metabolism and excretion of naproxen in various laboratory animals and human subjects. J. pharm. Sci. 1972; 61: 70332. Runkel R., Chaplin M., Boost G., Segre E., Forchielli E. Absorption, distribution, metabolism and excretion of naproxen in various laboratory animals and human subjects. J. pharm. Sci. 1972; 61: 703
   PubMed Web of Science ®Google Scholar
• Runkel R., Forchielli E., Sevelius H., Chaplin M., Segre E. Nonlinear plasma level response to high doses of naproxen. Clin. Pharmacol. Ther. 1974; 15: 26133. Runkel R., Forchielli E., Sevelius H., Chaplin M., Segre E. Nonlinear plasma level response to high doses of naproxen. Clin. Pharmacol. Ther. 1974; 15: 261
   PubMed Web of Science ®Google Scholar
• Runkel R. A., Kraft K. S., Boost G., Sevelius H., Forchielli E., Hill R., Magoun R., Szakacs J. B., Segre E. Naproxen oral absorption characteristics. Chem. pharm. Bull. 1972; 20: 145734. Runkel R. A., Kraft K. S., Boost G., Sevelius H., Forchielli E., Hill R., Magoun R., Szakacs J. B., Segre E. Naproxen oral absorption characteristics. Chem. pharm. Bull. 1972; 20: 1457
   PubMed Web of Science ®Google Scholar
• Segre E. J. Naprosyn metabolism in man. Naprosyn in the treatment of Rheumatic Diseases. Proceedings of a Symposium held in London, October 1973, 1973; 11, Syntex35. Segre E. J. Naprosyn metabolism in man. Naprosyn in the treatment of Rheumatic Diseases. Proceedings of a Symposium held in London, October 1973, 1973; 11, Syntex
   Google Scholar
• Segre E. J. Efficacy of Naprosyn in rheumatoid arthritis - placebo comparisons. Naprosyn in the treatment of Rheumatic Diseases. Proceedings of a Symposium held in London, October 1973, 1973; 17, Syntex36. Segre E. J. Efficacy of Naprosyn in rheumatoid arthritis - placebo comparisons. Naprosyn in the treatment of Rheumatic Diseases. Proceedings of a Symposium held in London, October 1973, 1973; 17, Syntex
   Google Scholar
• Segre E., Sevelius H., Chaplin M., Forchielli E., Runkel R., Rooks W. Interaction of naproxen and aspirin in the rat and in man. Scand. J. Rheumatol. 1973; 2: 37, Suppl.37. Segre E., Sevelius H., Chaplin M., Forchielli E., Runkel R., Rooks W. Interaction of naproxen and aspirin in the rat and in man. Scand. J. Rheumatol. 1973; 2: 37, Suppl.
   PubMedGoogle Scholar
• Steinbrocker O., Traeger C. H., Batterman R. C. Therapeutic criteria in rheumatoid arthritis. J. Amer. med. Ass. 1949; 140: 65938. Steinbrocker O., Traeger C. H., Batterman R. C. Therapeutic criteria in rheumatoid arthritis. J. Amer. med. Ass. 1949; 140: 659
   PubMed Web of Science ®Google Scholar
• Tomlinson R. V., Ringold H. J., Qureshi M. C., Forchielli E. Relationship between inhibition of prostaglandin synthesis and drug efficacy: support for the current theory on mode of action of aspirin-like drugs. Biochem. biophys. Res. Commun. 1972; 46: 55239. Tomlinson R. V., Ringold H. J., Qureshi M. C., Forchielli E. Relationship between inhibition of prostaglandin synthesis and drug efficacy: support for the current theory on mode of action of aspirin-like drugs. Biochem. biophys. Res. Commun. 1972; 46: 552
   PubMed Web of Science ®Google Scholar
• Webb J., Downie W. W., Dick W. C., Lee P. Evaluation of digital joint circumference measurements in rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 12740. Webb J., Downie W. W., Dick W. C., Lee P. Evaluation of digital joint circumference measurements in rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 127
   PubMedGoogle Scholar
• Willkens R. F. Double-blind crossover trial of naproxen and placebo in patients with rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 132, Suppl.41. Willkens R. F. Double-blind crossover trial of naproxen and placebo in patients with rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 132, Suppl.
   Google Scholar